Caarisma Shines at IMCAS 2024: A New Era in Aesthetic Medicine
Make it stand out
#2 CAARISMA – DR. RAINER POOTH
Caarisma utilizes a self-learning validated algorithm that is based on more than 200 variables in 17 landmarks to create a facial attractiveness index, facial youthfulness index, and a skin quality index. Drivers are identified to give information about the overall aesthetic status to assist the practitioner and inform patients.
The International Master Course on Aging Science (IMCAS) has long been a cornerstone of the aesthetic medicine landscape, providing invaluable insights and fostering innovation in the field. This year’s event, held in Paris, was the largest yet, drawing over 18,000 attendees to the Palais des Congrès. Amidst the backdrop of bustling construction in preparation for the upcoming Olympics, the atmosphere was charged with excitement and anticipation.
As a veteran of IMCAS for more than two decades, I have always been eager to explore trends and innovations beyond the U.S. market. The Innovation Tank and La Tribune sessions, in particular, stand out as must-attend events for any physician looking to stay ahead in the rapidly evolving world of medical aesthetics.
The Importance of Innovation at IMCAS
La Tribune, featuring industry luminaries like Umberto Antunes and keynote speaker Dr. Kathy Fields, provided a platform for engaging discussions about market trends, M&A activity, and pan-regenerative therapies. Attending these sessions not only enriches knowledge but also highlights the groundbreaking innovations that are set to shape the future of aesthetic medicine.
One such innovation that captured attention this year was Caarisma, which emerged as a significant player at the 2024 IMCAS Innovation Tribune.
Caarisma's Recognition: Innovation of the Year Runner-Up
Caarisma proudly secured the second place in the prestigious Innovation Tank, a recognition that underscores the app’s innovative approach to aesthetic assessment. The Innovation Tank, now in its seventh edition, offers a unique opportunity for entrepreneurs and startups to present their cutting-edge solutions in dermatology, plastic surgery, and aesthetics.
The award is determined by both a high-profile jury and audience votes, making it a true reflection of industry sentiment. Caarisma's self-learning validated algorithm, which analyzes over 200 variables across 17 facial landmarks, enables the creation of a Facial Attractiveness Index, Facial Youthfulness Index, and Skin Quality Index. These indices not only assist practitioners in evaluating their patients but also empower patients with clear insights into their aesthetic status.
Meeting the Needs of Aesthetic Medicine
The need for objective, reproducible, and holistic facial assessments in aesthetic medicine has never been greater. Caarisma addresses this gap by providing detailed analytics that help physicians and patients alike understand the key drivers of facial aesthetics. The insights garnered from the Caarisma app enable practitioners to tailor treatments more effectively, resulting in better patient outcomes and satisfaction.
Building Connections and Future Opportunities
Caarisma's participation in the IMCAS Innovation Tank was driven by a desire to gain visibility at the leading global congress in aesthetic medicine and to receive feedback from an esteemed jury. The response was overwhelmingly positive, resulting in numerous connections with global players in the field. These discussions have opened doors for potential licensing and partnership opportunities, positioning Caarisma as a frontrunner in the aesthetic market.
The Value of Evidence-Based Data
For future participants in the Innovation Tank, Caarisma emphasizes the importance of presenting evidence-based data. This not only strengthens the credibility of the innovation but also provides a solid foundation for discussions with potential partners and investors. The feedback received from the jury and audience can be instrumental in refining and enhancing the offerings of innovative solutions in aesthetic medicine.
Conclusion: The Future of Aesthetic Medicine with Caarisma
Caarisma’s recognition at IMCAS 2024 serves as a testament to the transformative potential of AI in aesthetic medicine. By providing a comprehensive digital health platform for practitioners and a beauty platform for consumers, Caarisma is poised to revolutionize the way aesthetic treatments are approached.
For physicians looking to enhance their practices, integrating Caarisma can facilitate informed patient consultations and ultimately improve treatment outcomes. The future of aesthetic medicine is bright, and with innovations like Caarisma leading the way, practitioners can look forward to a new era of objective assessment and personalized treatment options.
Backlinks
https://www.imcas.com/en/academy/blog/1042/discover-the-top-innovations-of2024
Caarisma MED is currently in its beta phase. Physicians interested in being at the forefront of this revolution can request a demo voucher and experience firsthand how AI is reshaping aesthetic consultations.
Curious about how AI can enhance your patients' beauty journey? Experience the Caarisma Consumer App yourself and see how patients gain personalized insights into their unique aesthetic potential. The app provides expert guidance, allows them to explore treatment options, and seamlessly connects them with your practice—all in one convenient platform.
www.caarisma.com for more information.